Extended Versus Intermittent Meropenem Infusion in the Treatment of Nosocomial Pneumonia: A Retrospective Single-Center Study

Extended Versus Intermittent Meropenem Infusion in the Treatment of Nosocomial Pneumonia: A Retrospective Single-Center Study

The efficacy of extended meropenem infusions in patients with nosocomial pneumonia is not well defined. Therefore, we compared the clinical outcomes of extended versus intermittent meropenem infusions in the treatment of nosocomial pneumonia. We performed a retrospective analysis of extended versus...

Full description

Bibliographic Details
Main Authors:	Dong-gon Hyun, Jarim Seo, Su Yeon Lee, Jee Hwan Ahn, Sang-Bum Hong, Chae-Man Lim, Younsuck Koh, Jin Won Huh
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Antibiotics
Subjects:	meropenem intensive care unit pneumonia ventilator-associated pneumonia intravenous infusion
Online Access:	https://www.mdpi.com/2079-6382/12/10/1542

Similar Items

Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia
by: Mona Ahmed Ammar, et al.
Published: (2018-01-01)

Continuous Piperacillin-Tazobactam Infusion Improves Clinical Outcomes in Critically Ill Patients with Sepsis: A Retrospective, Single-Centre Study
by: Dong-gon Hyun, et al.
Published: (2022-10-01)

Treatment of nosocomial pneumonia: an experience with meropenem
by: Santos Sigrid S., et al.
Published: (2001-01-01)

Treatment of nosocomial pneumonia: an experience with meropenem
by: Sigrid S. Santos, et al.

Case report: Successful experience using continuous infusion of meropenem in a geriatric patient with hip fracture complicated by sepsis
by: Assiya Kadralinova, et al.
Published: (2023-04-01)

Effects of Meropenem on Patients with Ventilator-Induced Pneumonia in Intensive Care Unit
by: Taraneh Naghibi, et al.
Published: (2022-11-01)

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
by: I. I. Shteynberg, et al.
Published: (2015-03-01)

In vitro activity of meropenem, imipenem, cefepime, cefoxitin and ciprofloxacin against multiresistant Klebsiella pneumoniae.
by: P Pruekprasert, et al.
Published: (2006-06-01)

Mortality of continuous infusion versus intermittent bolus of meropenem: a systematic review and meta-analysis of randomized controlled trials
by: Ming-Ying Ai, et al.
Published: (2024-03-01)

Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
by: Patrick M. Honore, et al.
Published: (2022-01-01)

Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial
by: Thomas Lodise, et al.
Published: (2020-09-01)

Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study
by: Hui-Ying Zhao, et al.
Published: (2017-01-01)

The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial
by: Mahnaz Momenzadeh, et al.
Published: (2023-01-01)

C/MIC > 4: A Potential Instrument to Predict the Efficacy of Meropenem
by: Yichang Zhao, et al.
Published: (2022-05-01)

Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study
by: Guangna Cao, et al.
Published: (2022-03-01)

Avaliação da atividade in vitro do meropenem contra cepas de Klebsiella pneumoniae produtoras de betalactamases de espectro expandido isoladas na cidade de Fortaleza, Ceará Evaluation of the in vitro activity of meropenem against strains of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in the city of Fortaleza, Ceará
by: Everardo Albuquerque Menezes, et al.
Published: (2007-06-01)

Comparison of in vitro activities of meropenem productions on Klebsiella pneumoniae isolated from hospitalized patients
by: Akhi, Mohammad Taghi, et al.
Published: (2014-08-01)

Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?
by: Beatriz Esteban-Cartelle, et al.
Published: (2024-01-01)

Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?
by: Beatriz Esteban-Cartelle, et al.
Published: (2024-02-01)

Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against <em>Pseudomonas aeruginosa</em> to Clinical Settings
by: Iris K. Minichmayr, et al.
Published: (2022-08-01)

Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial
by: Xue Tian, et al.
Published: (2022-11-01)

Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and <i>P. aeruginosa</i>
by: Pier Giorgio Cojutti, et al.
Published: (2020-08-01)

Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
by: Thomas De Corte, et al.
Published: (2023-04-01)

The In vitro Activity of Meropenem to Nosocomial Pseudomonas aeruginosa Isolates
by: Mustafa ÖZYURT, et al.
Published: (1998-09-01)

Nosocomial pneumonia in critically ill patients
by: Dandagi Girish
Published: (2010-01-01)

In vitro-obtained meropenem-vaborbactam resistance mechanisms among clinical Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates
by: Jacqueline Findlay, et al.
Published: (2023-03-01)

Inhalatory and intravenous colistin in treating ventilator-associated pneumonia due to acinetobacter species: Should we combine them?
by: Matijašević Jovan, et al.
Published: (2020-01-01)

Meropenem pharmacokinetics during relapsing peritonitis due to ESBL‐producing Enterobacteriaciae in a liver transplant recipient
by: Kensuke Shoji, et al.
Published: (2019-11-01)

Consenso colombiano de neumonía nosocomial 2013
by: Abraham Alí Munive, et al.

Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
by: Carla Troisi, et al.
Published: (2023-02-01)

A Novel KPC Variant KPC-55 in Klebsiella pneumoniae ST307 of Reinforced Meropenem-Hydrolyzing Activity
by: Eun-Jeong Yoon, et al.
Published: (2020-10-01)

Prediction of Minimal Inhibitory Concentration of Meropenem Against Klebsiella pneumoniae Using Metagenomic Data
by: Rundong Tan, et al.
Published: (2021-08-01)

Combined Use of Vancomycin and Meropenem in Patient with Acute Intermittent Porphyria: A Case Report
by: İrfan ŞENCAN, et al.
Published: (2004-09-01)

Exogenous glutathione reverses meropenem resistance in carbapenem-resistant Klebsiella pneumoniae
by: Juan Yi, et al.
Published: (2023-12-01)

Correction of target-controlled infusion following wrong selection of emulsion concentrations of propofol
by: Yun-Jeong Chae, et al.
Published: (2014-05-01)

Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan
by: Risako Takaya, et al.
Published: (2024-03-01)

Clinical, epidemiological and evolution of severe nosocomial pneumonia in intensive care unit
by: Abel Arroyo- Sanchez, et al.
Published: (2016-03-01)

Arrangements of the intravenous parallel infusions with anti-reflux valves decreasing occlusion alarm delay
by: Han Bum Joe, et al.
Published: (2014-04-01)

Características clínicas, epidemiológicas y evolución de la neumonía nosocomial severa en la unidad de cuidados intensivos
by: Edwin Albino H., et al.
Published: (2016-01-01)

Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations
by: A. Oliva, et al.
Published: (2023-06-01)